Edition:
India

People: Concert Pharmaceuticals Inc (CNCE.OQ)

CNCE.OQ on NASDAQ Stock Exchange Global Market

6.09USD
18 Oct 2019
Change (% chg)

$-0.43 (-6.60%)
Prev Close
$6.52
Open
$6.52
Day's High
$6.61
Day's Low
$6.04
Volume
60,623
Avg. Vol
60,171
52-wk High
$17.80
52-wk Low
$5.36

Cassella, James 

Dr. James V. Cassella Ph.D., is the Chief Development Officer of Concert Pharmaceuticals Inc, since February 2015. Prior to joining Concert, Dr. Cassella served as Executive Vice President, Research and Development and Chief Scientific Officer of Alexza Pharmaceuticals, Inc. from July 2012 to January 2015 and served as its Senior Vice President, Research and Development from June 2004 to July 2012. From April 1989 to April 2004, Dr. Cassella held various management positions at Neurogen Corporation, a publicly traded biotechnology company. Prior to Neurogen, Dr. Cassella was Assistant Professor of Neuroscience at Oberlin College. Dr. Cassella received a Ph.D. in Physiological Psychology from Dartmouth College, completed a postdoctoral fellowship in the Department of Psychiatry at the Yale University School of Medicine and received a B.A. in Psychology from the University of New Haven.

Basic Compensation

Total Annual Compensation, USD 406,445
Restricted Stock Award, USD 832,200
Long-Term Incentive Plans, USD --
All Other, USD 721,591
Fiscal Year Total, USD 1,960,240

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Aldrich

205,613

Roger Tung

4,607,850

Marc Becker

2,450,530

Nancy Stuart

1,908,030

James Cassella

1,960,240

Thomas Auchincloss

205,613
As Of  31 Dec 2018